Stock ADVENZYMES ADVANCED ENZYME TECHNOLOGIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Advanced Enzyme Technologies Limited Bombay S.E.

Equities

ADVENZYMES

INE837H01020

Specialty Chemicals

Delayed Bombay S.E.
Other stock markets
 05:46:37 2024-06-04 EDT 		5-day change 1st Jan Change
346.8 INR -3.61% Intraday chart for Advanced Enzyme Technologies Limited -6.96% -7.58%
05-15 Transcript : Advanced Enzyme Technologies Limited, Q4 2024 Earnings Call, May 15, 2024
05-11 Advanced Enzyme Technologies Limited Declares an Interim Dividend for the Financial Year 2024-2025, Payable on or Before June 5, 2024 CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 20,387 15,914 38,541 31,539 25,943 38,965 40,262 -
Enterprise Value (EV) 1 20,387 15,914 38,541 31,539 25,943 38,965 40,262 40,262
P/E ratio 18.4 x 12.3 x 26.4 x 26.4 x 24.6 x 29.2 x 22.5 x 19.1 x
Yield 0.33% - 0.26% 0.35% 0.43% - 0.56% 0.56%
Capitalization / Revenue 4.86 x 3.58 x 7.68 x 5.96 x 4.8 x - 5.74 x 5.1 x
EV / Revenue 4.86 x 3.58 x 7.68 x 5.96 x 4.8 x - 5.74 x 5.1 x
EV / EBITDA 11.2 x 7.65 x 16.6 x 15.7 x 16.6 x - 17 x 14.7 x
EV / FCF 17.5 x - 26.9 x 33.1 x 25.3 x - 13.9 x 19.1 x
FCF Yield 5.73% - 3.72% 3.03% 3.95% - 7.18% 5.23%
Price to Book 3.01 x 1.9 x 3.97 x 2.9 x 2.1 x - 2.72 x 2.41 x
Nbr of stocks (in thousands) 111,649 111,678 111,728 111,801 111,824 111,824 111,824 -
Reference price 2 182.6 142.5 345.0 282.1 232.0 348.4 360.0 360.0
Announcement Date 5/24/19 5/30/20 5/29/21 5/20/22 5/13/23 5/11/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,196 4,440 5,018 5,294 5,406 - 7,014 7,888
EBITDA 1 1,819 2,080 2,315 2,014 1,564 - 2,368 2,742
EBIT 1,608 - - - - - - -
Operating Margin 38.32% - - - - - - -
Earnings before Tax (EBT) 1 1,620 1,792 2,104 1,711 1,404 - 2,394 2,816
Net income 1 1,111 1,293 1,462 1,196 1,056 1,333 1,797 2,114
Net margin 26.47% 29.12% 29.13% 22.59% 19.54% - 25.62% 26.8%
EPS 2 9.940 11.56 13.07 10.68 9.450 11.92 16.00 18.90
Free Cash Flow 1 1,168 - 1,435 954.2 1,024 - 2,892 2,105
FCF margin 27.84% - 28.59% 18.02% 18.95% - 41.23% 26.69%
FCF Conversion (EBITDA) 64.21% - 61.96% 47.37% 65.48% - 122.13% 76.77%
FCF Conversion (Net income) 105.17% - 98.13% 79.79% 96.97% - 160.93% 99.57%
Dividend per Share 2 0.6000 - 0.9000 1.000 1.000 - 2.000 2.000
Announcement Date 5/24/19 5/30/20 5/29/21 5/20/22 5/13/23 5/11/24 - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 1,168 - 1,435 954 1,024 - 2,892 2,105
ROE (net income / shareholders' equity) 17.9% 17% 15.1% 11% 8.71% - 12.1% 16%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 60.80 75.20 86.90 97.40 110.0 - 132.0 149.0
Cash Flow per Share - - - - - - - -
Capex 1 118 - 194 269 379 - 300 300
Capex / Sales 2.8% - 3.87% 5.08% 7.02% - 4.28% 3.8%
Announcement Date 5/24/19 5/30/20 5/29/21 5/20/22 5/13/23 5/11/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
360 INR
Average target price
470 INR
Spread / Average Target
+30.54%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
ECOLAB INC. Stock Ecolab Inc.
+17.43% 66.51B
SIKA AG Stock Sika AG
-2.08% 48.51B
GIVAUDAN SA Stock Givaudan SA
+21.21% 43.41B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+27.96% 27.76B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 19.11B
CELANESE CORPORATION Stock Celanese Corporation
-4.65% 16.18B
SYMRISE AG Stock Symrise AG
+9.75% 16.58B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-16.33% 14.21B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-28.97% 14.39B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. ADVENZYMES Stock
  4. ADVENZYMES Stock
  5. Financials Advanced Enzyme Technologies Limited